×

Spark gene therapy drug priced less than expected at $850,000

8:34 AM ET Wed, 3 Jan 2018

CNBC's Meg Tirrell reports Spark Therapeutics' Luxturna, which treats an inherited form of vision loss, will come to market under $1 million.